Categories
Change Password!
Reset Password!
Adolescents with PCOS-related acne experience notable racial differences in dermatologic treatment, particularly in access to hormonal and advanced therapies.
Polycystic ovary syndrome (PCOS) frequently develops during adolescence and is commonly associated with acne vulgaris, which can significantly affect quality of life and psychosocial well-being. Understanding prescribing patterns in younger patients is increasingly important for advancing equitable dermatologic care. The study investigated racial and ethnic variations in acne treatment patterns among adolescents diagnosed with PCOS.
Investigators conducted a retrospective review of electronic medical records from a single medical center. Female patients younger than 18 years with documented PCOS and acne vulgaris were included in the analysis. Demographic characteristics, clinical findings, and prescribed acne therapies were collected and evaluated. Statistical comparisons between racial and ethnic groups were performed using chi-square and Fisher’s exact tests, while multivariable logistic regression analyses adjusted for acne severity, insurance coverage, and interpreter utilization.
The analysis included 138 adolescents representing diverse racial and ethnic backgrounds, with moderate acne observed in 52.2% of the cohort.
These prescribing differences persisted even after adjustment for acne severity and healthcare access-related factors. The findings revealed persistent racial and ethnic inequities in dermatologic treatment among adolescents with PCOS-related acne. Reduced prescribing of hormonal and advanced acne therapies in Hispanic patients, along with lower topical antibiotic use in Black patients, suggested that factors beyond clinical severity and healthcare access may contribute to treatment variation.
Pediatric Dermatology
Racial Differences in Dermatologic Treatment for Adolescents With PCOS-Related Acne Vulgaris
Samantha Garcia et al.
Comments (0)